Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) EBT (2016 - 2026)

Champions Oncology has reported EBT over the past 17 years, most recently at -$237000.0 for Q1 2026.

  • Quarterly results put EBT at -$237000.0 for Q1 2026, down 105.25% from a year ago — trailing twelve months through Jan 2026 was -$2.4 million (down 137.46% YoY), and the annual figure for FY2025 was $4.6 million, up 163.3%.
  • EBT for Q1 2026 was -$237000.0 at Champions Oncology, down from $255000.0 in the prior quarter.
  • Over the last five years, EBT for CSBR hit a ceiling of $4.5 million in Q1 2025 and a floor of -$2.5 million in Q2 2023.
  • Median EBT over the past 5 years was -$302000.0 (2022), compared with a mean of -$466411.8.
  • Biggest five-year swings in EBT: plummeted 102900.0% in 2023 and later skyrocketed 279.36% in 2025.
  • Champions Oncology's EBT stood at -$2000.0 in 2022, then plummeted by 102900.0% to -$2.1 million in 2023, then skyrocketed by 135.87% to $739000.0 in 2024, then crashed by 65.49% to $255000.0 in 2025, then crashed by 192.94% to -$237000.0 in 2026.
  • The last three reported values for EBT were -$237000.0 (Q1 2026), $255000.0 (Q4 2025), and -$452000.0 (Q3 2025) per Business Quant data.